Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
J Clin Endocrinol Metab ; 97(10): 3613-21, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22893718

RESUMEN

CONTEXT: Gestational diabetes mellitus (GDM)-associated hormonal and metabolic derangements in mother and fetus affect placental development and function. Indeed, in GDM, placentas are characterized by hypervascularization and vascular dysfunction. The membrane-type matrix metalloproteinase 1 (MT1-MMP) is a key player in angiogenesis and vascular expansion. OBJECTIVE: Here, we hypothesized elevated placental MT1-MMP levels in GDM induced by components of the diabetic environment. Therefore, we measured placental MT1-MMP in normal vs. GDM pregnancies, identified potential functional consequences, and investigated the contribution of hyperglycemia and the insulin/IGF axis. DESIGN: Immunohistochemistry identified placental cell types expressing MT1-MMP. MT1-MMP was compared between normal and GDM placentas by immunoblotting. Quantitative PCR of MT1-MMP in primary feto-placental endothelial cells (fpEC) and trophoblasts isolated from both normal and GDM placentas identified the cells contributing to the GDM-associated changes. A putative MT1-MMP role in angiogenesis was determined using blocking antibodies for in vitro angiogenesis assays. Potential GDM-associated factors and signaling pathways inducing MT1-MMP up-regulation in fpEC were identified using kinase inhibitors. RESULTS: Total and active MT1-MMP was increased in GDM placentas (+51 and 54%, respectively, P<0.05) as a result of up-regulated expression in fpEC (2.1-fold, P=0.02). MT1-MMP blocking antibodies reduced in vitro angiogenesis up to 25% (P=0.03). Pathophysiological levels of insulin and IGF-II, but not IGF-I and glucose, stimulated MT1-MMP expression in fpEC by phosphatidylinositol 3-kinase signals relayed through the insulin, but not IGF-I, receptor. CONCLUSIONS: GDM up-regulates MT1-MMP in the feto-placental endothelium, and insulin and IGF-II contribute. This may account for GDM-associated changes in the feto-placental vasculature.


Asunto(s)
Diabetes Gestacional/metabolismo , Feto/metabolismo , Factor II del Crecimiento Similar a la Insulina/metabolismo , Insulina/metabolismo , Metaloproteinasa 14 de la Matriz/metabolismo , Placenta/metabolismo , Adulto , Células Endoteliales/citología , Células Endoteliales/metabolismo , Femenino , Glucosa/metabolismo , Humanos , Hiperglucemia/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Neovascularización Fisiológica/fisiología , Placenta/irrigación sanguínea , Placenta/citología , Embarazo , Tercer Trimestre del Embarazo/metabolismo , Cultivo Primario de Células , Trofoblastos/citología , Trofoblastos/metabolismo , Regulación hacia Arriba/fisiología
2.
Placenta ; 32 Suppl 2: S90-9, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21236487

RESUMEN

Workshops are an important part of the IFPA annual meeting. At IFPA Meeting 2010 diverse topics were discussed in twelve themed workshops, six of which are summarized in this report. 1. The placental pathology workshop focused on clinical correlates of placenta accreta/percreta. 2. Mechanisms of regulation of trophoblast invasion and spiral artery remodeling were discussed in the trophoblast invasion workshop. 3. The fetal sex and intrauterine stress workshop explored recent work on placental sex differences and discussed them in the context of whether boys live dangerously in the womb.4. The workshop on parasites addressed inflammatory responses as a sign of interaction between placental tissue and parasites. 5. The decidua and embryonic/fetal loss workshop focused on key regulatory mediators in the decidua, embryo and fetus and how alterations in expression may contribute to different diseases and adverse conditions of pregnancy. 6. The trophoblast differentiation and syncytialisation workshop addressed the regulation of villous cytotrophoblast differentiation and how variations may lead to placental dysfunction and pregnancy complications.


Asunto(s)
Feto , Placenta , Trofoblastos/fisiología , Animales , Diferenciación Celular/fisiología , Fusión Celular , Movimiento Celular/fisiología , Decidua/fisiología , Decidua/fisiopatología , Educación , Femenino , Feto/citología , Feto/parasitología , Feto/patología , Feto/fisiología , Feto/fisiopatología , Humanos , Masculino , Enfermedades Parasitarias/inmunología , Enfermedades Parasitarias/metabolismo , Enfermedades Parasitarias/patología , Enfermedades Parasitarias/fisiopatología , Placenta/citología , Placenta/parasitología , Placenta/patología , Placenta/fisiología , Placenta/fisiopatología , Placenta Accreta/etiología , Placenta Accreta/metabolismo , Placenta Accreta/patología , Placenta Accreta/fisiopatología , Embarazo , Complicaciones del Embarazo/metabolismo , Complicaciones del Embarazo/fisiopatología , Resultado del Embarazo , Caracteres Sexuales , Estrés Fisiológico/fisiología , Trofoblastos/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA